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presenting to the Emergency Department
with suspected systemic infection
Christina A. Rostad1,2*, Neena Kanwar3, Jumi Yi1,2, Claudia R. Morris1,2, Jennifer Dien Bard4, Amy Leber5,
James Dunn6, Kimberle C. Chapin7, Anne J. Blaschke8, Judy A. Daly9, Leslie A. Hueschen10, Matthew Jones11,
Elizabeth Ott11, Jeffrey Bastar11, Kevin M. Bourzac11 and Rangaraj Selvarangan3

Abstract
Background: Fever is a common symptom in children presenting to the Emergency Department (ED). We aimed
to describe the epidemiology of systemic viral infections and their predictive values for excluding serious bacterial
infections (SBIs), including bacteremia, meningitis and urinary tract infections (UTIs) in children presenting to the ED
with suspected systemic infections.
Methods: We enrolled children who presented to the ED with suspected systemic infections who had blood
cultures obtained at seven healthcare facilities. Whole blood specimens were analyzed by an experimental
multiplexed PCR test for 7 viruses. Demographic and laboratory results were abstracted.
Results: Of the 1114 subjects enrolled, 245 viruses were detected in 224 (20.1%) subjects. Bacteremia, meningitis
and UTI frequency in viral bloodstream-positive patients was 1.3, 0 and 10.1% compared to 2.9, 1.3 and 9.7% in viral
bloodstream-negative patients respectively. Although viral bloodstream detections had a high negative predictive
value for bacteremia or meningitis (NPV = 98.7%), the frequency of UTIs among these subjects remained
appreciable (9/89, 10.1%) (NPV = 89.9%). Screening urinalyses were positive for leukocyte esterase in 8/9 (88.9%) of
these subjects, improving the ability to distinguish UTI.
Conclusions: Viral bloodstream detections were common in children presenting to the ED with suspected systemic
infections. Although overall frequencies of SBIs among subjects with and without viral bloodstream detections did
not differ significantly, combining whole blood viral testing with urinalysis provided high NPV for excluding SBI.
Keywords: Viremia, Pediatrics, Serious bacterial infections, Enterovirus, Adenovirus, Parvovirus B19, Cytomegalovirus,
Human parechovirus

* Correspondence: Christina.rostad@emory.edu
1
Department of Pediatrics, Emory University School of Medicine, 2015
Uppergate Drive NE, Atlanta, GA 30322, USA
2
Children’s Healthcare of Atlanta, Atlanta, GA, USA
Full list of author information is available at the end of the article
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.

Rostad et al. BMC Pediatrics

(2021) 21:238

Background
Fever is a common symptom in children presenting to
the Emergency Department (ED). Although the incidence
of serious bacterial infections (SBIs) in febrile children has
decreased since the implementation of routine immunizations against Streptococcus pneumoniae [1, 2] and Haemophilus influenzae type b [3], up to 7.2% of febrile
children < 5 years of age have either urinary tract infection,
pneumonia, or occult bacteremia [4]. Distinguishing patients with SBIs from those with self-limited viral infections
or non-infectious illnesses is often challenging due to nonspecific clinical findings and laboratory parameters [4].
This can lead to unnecessary hospitalizations and increased
healthcare burden. Recent studies have demonstrated that
rapid identification of pathogens using molecular testing
can reduce unnecessary antibiotic administration, duration
of hospitalization, and costs [5]. However, the current epidemiology of systemic viral infections and their predictive
values for excluding SBIs in febrile children is unknown.
In this study, we utilized an experimental multiplexed
viral PCR test to describe the epidemiology of seven viral
bloodstream infections in children presenting to the ED
with suspected systemic infection who had blood cultures obtained at seven U.S. sites. Our cohort broadly
included children with fever with and without a source,
and special populations including neonates and immunocompromised children. We then performed statistical
comparisons to determine the associations between viral
bloodstream detections, bacterial cultures, and other
standard-of-care tests.
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Once enrolled, chart review was performed to abstract
subject data including age, sex, hospitalization status,
date of specimen collection, ED discharge diagnoses, and
standard-of-care laboratory test results, including blood,
cerebrospinal fluid (CSF), and urine cultures. For this
study, an SBI was defined as a bacterial bloodstream infection, meningitis, or a urinary tract infection (UTI). A
bacterial bloodstream infection was defined as growth of
a pathogenic organism in one or more blood cultures.
We excluded detection of presumed contaminating organisms, including coagulase-negative staphylococcus
(CoNS), viridans streptococcus (other than Streptococcus
anginosus group), Micrococcus sp., and Corynebacterium
sp. Although these organisms can represent true pathogens in immunocompromised hosts, none were isolated
on more than one repeated culture, and thus they were
considered unlikely to be true pathogens. Bacterial meningitis was defined as growth of a pathogenic organism
from the cerebrospinal fluid. Urinary tract infection was
defined as having growth of a single pathogen at ≥50,000
colony forming units (CFU/mL), or if multiple potential
pathogenic organisms were present, growth of a predominant pathogen at ≥50,000 CFU/mL. We excluded
cultures with other polymicrobial growth, growth < 50,
000 CFU/mL, growth of non-bacterial organisms (e.g.
Candida albicans), growth of organisms which were not
identified to the genus level (e.g. Gram-positive cocci),
and growth of presumed contaminating organisms, such
as CoNS and Bacillus sp.
Multiplexed PCR testing

Methods
Subject enrollment

This study received Institutional Review Board (IRB)
approval for each of the seven geographically distinct
U.S. sites for enrollment and testing over a period of 17
months (March 2017 to July 2018). Children < 18 years
of age were enrolled prospectively if they met the following inclusion criteria: (1) Presented to the ED with
suspected systemic infection indicated by a clinicianordered blood culture; (2) parent/guardian gave written
informed consent (and subject gave assent if of sufficient
age and maturity); (3) blood specimen was collected during the ED visit or within 12 h of being admitted from
the ED; (4) blood specimen was at least 500 μL; and (5)
specimen could be aliquoted and tested or frozen within
1 day while stored at 4 °C. All specimens were coded
such that they were not individually identifiable and so
that the results of the experimental PCR testing could
not be used to inform patient care. The IRB at one site
(Emory University, IRB00096348) provided waiver of
informed consent for clinical investigations involving no
more than minimal risk to human subjects (https://
www.fda.gov/media/106597/download).

Whole blood was aliquoted and analyzed using an experimental multiplexed viral PCR (emvPCR) test based
on the BioFire® FilmArray® System. The BioFire System
is a test platform that is able to detect multiple pathogens
from a variety of specimen types using an automated sample purification, multiplex-nested PCR, and amplicon melt
analysis approach [6].
This study represents an analysis of results obtained from
a pilot evaluation of the emvPCR test to identify viruses
from whole blood of children presenting to the ED with
suspected systemic infections. Viral targets on the emvPCR
included adenovirus, cytomegalovirus (CMV), enterovirus,
human parechovirus, herpes simplex virus 1 (HSV-1),
herpes simplex virus 2 (HSV-2), and parvovirus B19. These
targets were chosen because they are either common or
high-risk pathogens associated with viremia in infants or
children [7–9]. The emvPCR test provided automated interpretation of results as either “Detected” or “Not Detected”
for each target, but did not provide PCR cycle threshold (Ct)
values. During the course of the 17-month pilot study, the
emvPCR test underwent two modifications to the thermocycling parameters to increase the sensitivity of the viral assays,
which is an inherent limitation of the study.
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Statistical analysis

Statistical analyses were performed using Microsoft
Excel and GraphPad Prism version 8.0.2. Continuous
variables were expressed as medians and interquartile
ranges (IQRs). Categorical variables were expressed as
the absolute number of subjects and relative percentages. Comparisons were made using Student’s t-tests or
one-way analysis of variance (ANOVA) for continuous
variables and Fisher’s Exact tests for categorical variables
with results reported as odds ratios with 95% confidence
intervals. P-values ≤0.05 were considered statistically
significant.

Results
Summary of emvPCR test findings

Of the 1114 subjects enrolled at seven participating sites,
519 (46.6%) were female and the median age was 42
months (IQR 13 to 98.8 months). A total of 245 viruses
were detected in whole blood collected from 224/1114
(20.1%) distinct patients (Fig. 1a), 10 (4.5%) of whom
had concomitant SBIs. The most commonly detected
virus was enterovirus (125/245, 51.0%), followed by
adenovirus (49/245, 20.0%), CMV (33/245, 13.5%),
parvovirus B19 (32/245, 13.1%), and human parechovirus (6/245, 2.5%). HSV-1 and HSV-2 were not detected. Of those who had viral detections, the majority
were single viruses (Fig. 1b). However, 14 (6.3%) of
subjects had two viruses detected, two (0.9%) had three
viruses, and one patient (0.4%) had four viruses detected.
Although enterovirus was the most frequently identified
virus in all age groups (Fig. 1c), it accounted for a larger
proportion of viral detections in the youngest age groups
(ages < 2 months and 2 to 6 months) (P < 0.0001). In
contrast, parvovirus B19 was only identified in children
> 6 months of age.
Summary of standard of care test results

Sixty-three subjects (63/1114, 5.7%) were found to have
serious bacterial infections, which consisted of 29 bloodstream infections, 37 urinary tract infections, and one case
of bacterial meningitis (Table 1). Four of these subjects
had concurrent blood and urine cultures positive for the
same organism.
Among the subjects with bacterial bloodstream infections, six had Staphylococcus aureus and five had Escherichia coli bacteremia. One subject each had Salmonella
Typhi, Samonella non-Typhi, Bacteroides fragilis, Enterococcus faecalis, S. anginosus group, Streptococcus agalactiae,
and Streptococcus pneumoniae. The remainder had Gramnegative rod bacteremia, with the exception of one subject
who had both Candida parapsilosis and Staphylococcus
simulans and was classified as having an SBI with diagnosis
of a central-line associated tunnel infection. Thirty-five
additional subjects had positive blood cultures growing

Fig. 1 Viral detections in children presenting to the Emergency
Department with suspected systemic infection. a Distribution of
organisms detected in whole blood specimens by the emvPCR test or
by standard-of-care bacterial cultures. b Viruses detected as single or
co-infections. c Percentage of viruses detected by age group. emvPCR:
experimental multiplexed viral PCR. SBI: Serious bacterial infection

presumed contaminants which were not isolated on subsequent blood cultures. These organisms were CoNS, viridans
streptococcus (other than S. anginosus group), Micrococcus
sp., and Corynebacterium sp. Thus, the majority of positive
blood cultures in children presenting to the ED with suspected bloodstream infection (35/64, 54.7%) represented
presumed contaminating organisms.
Of the 383 subjects who had urine cultures performed,
37 (9.7%) had a UTI defined as a urine culture growing
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Table 1 Standard-of-care (SOC) culture results with respect to viral pathogen detections by the emvPCR test
Viral targets on emvPCR test, n(%)

Bloodstream infection
(n = 29)

Urinary tract infection
(n = 37)a

Bacterial meningitis
(n = 1)b

Any SBI
(n = 63)c

Adenovirus (n = 49)

1/49 (2.0%)

1/18 (5.6%)

0/3 (0%)

1/49 (2.0%)

Cytomegalovirus (n = 33)

1/33 (3.0%)

1/13 (7.7%)

0/1 (0%)

2/33 (6.1%)

Enterovirus (n = 125)

0/125 (0%)

6/59 (10.2%)

0/13 (0%)

6/125 (4.8%)

Human parechovirus (n = 6)

1/6 (16.7%)

1/4 (25.0%)

0/2 (0%)

1/6 (16.7%)

Parvovirus B19 (n = 32)

0/32 (0%)

0/3 (0%)

0/0 (0%)

0/32 (0%)

All viral positives (n = 224)

3/224 (1.3%)

9/89 (10.1%)

0/21 (0%)

10/224 (4.5%)

All viral negatives (n = 890)

26/890 (2.9%)

28/294 (9.5%)

1/59 (1.7%)

53/890 (6.0%)

Total

29/1114 (2.6%)

37/383 (9.7%)

1/80 (1.3%)

63/1114 (5.7%)

a

Denominator represents the number of subjects who had urine cultures performed
b
Denominator represents the number of subjects who had CSF cultures performed
c
Total number of SBIs may be less than sum of individual SBIs if individual subjects had multiple types of SBIs

a predominant uropathogen at ≥50,000 CFU/ mL.
Thirty-four of these (34/37, 91.9%) screened positive by
leukocyte esterase on urinalysis, whereas only 12 (12/37,
32.4%) had positive nitrites. All patients with UTIs with
nitrites detected on their urinalyses were also positive
for leukocyte esterase. An additional 38 (9.9%) of
subjects grew contaminating organisms or pathogens at
a concentration less than the defined threshold for the
diagnosis of UTI. The single subject with bacterial meningitis grew Neisseria meningitidis from his CSF culture.
Standard of care results with respect to viral detections

The frequency of SBIs in subjects with emvPCR viral
detections was similar to those without viral infections
(10/224 [4.5%] vs. 53/890 [6.0%], P = 0.5168) (Table 1).
This was true for each type of SBI, including bacteremia
(3/224 [1.3%] vs. 26/890 [2.9%], P = 0.2423), UTI (9/89
[10.1%] vs. 28/294 [9.5%], P = 0.8396), and meningitis (0/
21 [0.0%] vs. 1/59 [1.7%], P > 0.9999). Among the 10
subjects who had viral and bacterial co-infections, all
had single viral detections, the majority (6/10, 60%) had
enterovirus and urinary tract infections, and 5/6 of these
subjects were < 2 years of age. Only three subjects in our
study had concurrent viral and bacterial bloodstream infections. One patient had E. coli urosepsis and adenovirus in the blood, the second had E. coli urosepsis and
human parechovirus in the blood, and the third had E.
coli sepsis and CMV detected in the blood. Thus, the
negative predictive value of a viral bloodstream detection
for bacteremia or bacterial meningitis was high (221/
224, NPV = 98.7%). The sensitivity of a negative bloodstream PCR test for identifying SBI was (26/29) 90.0%,
and the specificity was low (221/1085, 20.3%). The
frequency of UTIs among participants with viral detections also remained appreciable (9/89, 10.1%) (NPV =
89.9%). The sensitivity of a negative bloodstream PCR
test for identifying UTI was (28/9) 75.7%, while the
specificity was low (80/346, 23.1%).

Participants with systemic viral infections alone were
younger (Median 19 mos, IQR 7–56.6) than those with
no pathogen detected (Median 48, IQR 17–111) (P <
0.0001), but similar in age to those SBI (Median 30 mos,
IQR 9.5–86) (Table 2). Whereas younger age was associated with systemic viral infection, female sex was associated with lower odds of systemic viral infection
compared to SBI (OR 0.46, 95% CI 0.25–0.82, P =
0.0094). Pyuria was also a significant predictor of UTI,
but CSF pleocytosis (WBC > 5 cells/uL) was not a predictor of bacterial meningitis, although the frequency of
bacterial meningitis was low, viral etiologies of meningoencephalitis were not analyzed, and we were unable to
correct for confounding factors such as bloody lumbar
punctures. The overall sensitivity and specificity of
pyuria for predicting UTI among subjects who had urinalyses performed were (34/37) 91.9% and (516/586)
88.1% respectively. However, the sensitivity and specificity of leukocytosis (WBC ≥ 15,000 cells/uL) for any SBI
was low at 47.6 and 78.9% respectively. Participants with
systemic viral infections alone had decreased odds of
hospitalization compared to children with SBIs (OR
0.22, 95% CI 0.11–0.44, P < 0.0001).
Although respiratory PCR diagnostics were not
performed systematically on enrolled subjects, standardof-care results for such tests were collected and recorded. Of the 1114 enrolled subjects, 438 (39.3%) had
respiratory PCRs performed per standard of care on
upper and/or lower respiratory specimens, and 217
(49.5%) had positive detections. The frequency of SBIs in
subjects with respiratory viral infections was similar to
those without respiratory viral infections (10/217 [4.6%]
vs. 53/897 [5.9%], P = 0.5164) (Supplemental Table S1).
This was true for each type of SBI, including bacteremia
(4/218 [1.8%] vs. 25/897 [2.8%], P = 0.6340), UTI (30/293
[10.2%] vs. 37/383 [9.7%], P = 0.8342), and meningitis (0/
20 [0.0%] vs. 1/60 [1.7%], P > 0.9999). Predictors of
respiratory viral infections included younger age, male
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Table 2 Demographic and laboratory characteristics of subjects with systemic viral infections alone (by emvPCR test); any systemic
bacterial infection (SBI); or no systemic virus or bacterial infection. emvPCR experimental multiplexed viral PCR, WBC white blood cell
count, LE leukocyte esterase, CSF cerebrospinal fluid, UTI urinary tract infection
Systemic virus only
(n = 214)

Any SBI
(n = 63)

No systemic virus or SBI
(n = 837)

Odds Ratio
(95% CI)a

P-valuea

Age, mos, median (IQ range)

19 (7–56.5)

30 (9.5–86)

48 (17–111)

–

0.2629
< 0.0001

Sex, female, n (%)

91/214 (42.5%)

39/63 (61.9%)

389/837 (46.5%)

0.46 (0.25–0.82)
0.85 (0.63–1.16)

0.0094
0.3180

Season, fall/winter, n (%)

144/214 (67.3%)

39/63 (61.9%)

532/837 (63.6%)

1.27 (0.71–2.22)
1.18 (0.86–1.62)

0.451
0.3376

Hospitalized, n (%)

108/214 (50.5%)

52/63 (82.5%)

469/837 (53.0%)

0.22 (0.11–0.44)
0.80 (0.60–1.07)

< 0.0001
0.1658

WBC, median (IQ range)

10.3 (7.3–15.0)

10.9 (8.6–18.1)

9.6 (6.5–13.6)

–

0.5399
0.2347

Pyuria (+LE), n (%)b

11/207 (5.3%)

37/47 (78.7%)

56/366 (15.3%)

0.01 (0.01–0.04)
0.31 (0.16–0.59)

< 0.0001
0.0002

CSF WBC > 5/μL, n (%)c

7/16 (43.8%)

4/11 (36.4%)

19/45 (42.2%)

1.36 (0.28–5.44)
1.06 (0.35–3.62)

> 0.9999
> 0.9999

a
Top line compares “Systemic virus only” and “Any SBI” groups. Bottom line compares “Systemic virus only” and “No systemic virus or SBI” groups. For categorical
variables, odds ratios and 95% confidence intervals were calculated using Fisher’s exact test. For continuous variables, P-values were calculated using one-way
ANOVA with Tukey’s post-hoc multiple comparisons test
b
Denominator represents the number of subjects who had urinalyses with leukocyte esterase performed
c
Denominator represents the number of subjects who had CSF WBC performed

gender, fall/winter season, and lack of pyuria on screening
urinalysis (Supplemental Table S2). The hospitalization
rate for children with respiratory viral infections was lower
than that of subjects with SBIs, but higher than that of
subjects with no virus or SBI detected.
Of the 7 viruses included in the emvPCR panel, adenovirus and rhinovirus/enterovirus were also identified in
respiratory PCR panels. Of the 29 adenovirus detections
in the blood, 12 (41.4%) were also detected by respiratory PCR. Similarly, of the 49 patients who had enterovirus detections in the blood, 22 (44.9%) were also
detected by respiratory PCR panel as rhinovirus/enterovirus. Concordance of results between whole blood and
respiratory samples for both positive and negative detections for was 418 /438 (95.4%) for adenovirus and 344/
438 (78.5%) for enterovirus. The lower concordance of
rhinovirus/enterovirus PCR results may be attributable
to the overrepresentation of rhinovirus compared to
enterovirus in the nasopharynx, the lower likelihood of
rhinovirus viremia, and the inability of the multiplexed
PCR panels to distinguish between the two viruses.

Discussion
In this study, we describe the epidemiology of seven viral
bloodstream detections in children presenting to the ED
with suspected systemic infection at seven geographically
distinct U.S. sites. Viruses were detected in the bloodstream of 224/1114 (20.1%) subjects, the majority of which
were enterovirus, followed by adenovirus, CMV, parvovirus B19, and human parechovirus. HSV-1 and HSV-2
were not detected. The predominance of enterovirus is

consistent with previously reported data in young febrile
children without a source [8, 10–12]. Of those who had
positive viral detections, the majority were single viruses;
however 17/224 (7.6%) of subjects had two or more
viruses detected. While some of these were thought to
represent true viral co-infections, CMV or parvovirus B19
co-detections may have alternatively represented viral latency or reactivation.
There was not a significant difference in the frequency
of SBIs among subjects with viral bloodstream infections
(10/224, 4.5%) vs. those without them (53/890, 6.0%),
(P = 0.5168). These findings contrast with a recently
published prospective single-center study by L’Huillier,
et al. which found significant differences in the frequency of SBIs among virally infected and non-infected
children < 3 years of age presenting to the ED with fever
without a source. The discrepancy may in part be
explained by the distinct patient population and by the
higher frequency of SBIs observed among subjects without viral infections (20.5%) [10]. L’Huillier, et al. also included human herpesvirus 6 (HHV-6) in their study,
which is a commonly reported cause of viremia in febrile
young children. Similarly, Byington, et. al found significant differences in the frequency of SBIs among virally
infected and non-infected infants < 90 days of age. The
higher frequency of SBIs observed in this study may
have been attributable to inclusion of pneumonia and
soft tissue infections as SBIs, and may also be a reflection of the higher frequency of SBIs in young infants
compared to the general pediatric population [9]. Nevertheless, both the L’Huillier study and our study found a
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similar risk of UTI in virally infected children. Of the
ten subjects in our study with viral and bacterial coinfections, nine had UTIs, and six had concurrent enterovirus infections. This data corroborates multiple
studies which have found the risk of UTI in febrile
children with other clinically significant viral infections,
including influenza [13] and respiratory syncytial virus
(RSV) [14, 15] to be low, but still appreciable.
In the current era, UTIs are the most common form
of SBI in febrile children without a source [2], which is
consistent with the data reported herein. Although viral
detections alone did not sufficiently exclude the diagnosis of UTI, the majority of patients with concurrent viral
detections and UTIs had screening urinalyses positive
for leukocyte esterase (8/9, 88.9%). The overall sensitivity
and specificity of leukocyte esterase for UTI was moderately high, at 91.9 and 88.1%, respectively. Female sex
was also a significant predictor of SBI, primarily due to a
higher frequency of UTIs in females. Thus, the combination of viral molecular testing, clinical factors, and
screening urinalyses were helpful predictors of SBIs. In
contrast, leukocytosis was poorly predictive of viral or
bacterial infection, which is consistent with previously
reported literature [16]. CSF pleocytosis was similarly
poorly predictive of SBI, although the frequency of
bacterial meningitis in our study was very low and viral
etiologies of meningoencephalitis were not analyzed.
Among febrile children without a clear diagnosis of
SBI, Colvin, et al. found viral etiologies in up to 76% of
subjects when both bloodstream and respiratory samples
were systematically analyzed [8]. This estimate is higher
than what was observed in the current study, likely because Colvin, et al. systematically analyzed respiratory
samples for all patients and included additional viruses.
Some of these viruses were of less certain clinical significance [HHV-6, bocavirus, WU virus, KI virus, BK virus],
and a high rate of viruses were detected in subjects with
SBIs and afebrile controls. Our study highlights that although viruses are frequently detected in the bloodstream of children presenting to the ED with suspected
systemic infections, they are not adequate predictors of
the presence or absence of SBIs alone. Although the detection of systemic viruses had high negative predictive
value for bacteremia and meningitis, the risk of UTI
remained appreciable. Thus, viral molecular testing of
the bloodstream must be interpreted in the context of
clinical risk factors and laboratory parameters, including
screening urinalyses, markers of systemic inflammation,
and clinical appearance of the child.
The interpretation of viral detections must also take
into consideration virus- and host-specific factors, such
as the timing and duration of viremia following infection
and the age and immune status of the host. For example,
in a prospective, multicenter study, Lafolie,et al. found
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that the sensitivity of blood enterovirus PCR testing is
dependent upon the patient’s age and clinical presentation [17]. Detection of enterovirus was more sensitive in
blood samples than CSF samples of newborns and infants with fever and sepsis-like diseases, but was less
frequent in older children with suspected meningitis. In
the case of adenovirus, viremia is much more common
in immunocompromised children, who may experience
prolonged viral shedding [18]. And in the case of parvovirus B19, acute viremia occurs 1–2 weeks after infection, but can persist at low levels for months to years
[19]. Thus, detection of parvovirus B19 by DNA PCR in
the bloodstream does not necessarily indicate acute
infection.
This study had some key limitations. First, not all
viruses of potential clinical importance were included in
the multiplexed test. Omitted viruses included some
herpesviruses such as Epstein-Barr virus (EBV), human
herpesvirus 6 (HHV-6), and human herpesvirus 7
(HHV-7), whose results can be complicated by false positives in whole blood specimens due to latently infected
B cells. This may have also been the case for CMV, another herpesvirus, which was included in the current
study. Second, this study did not systematically assess
for focal bacterial infections such as pneumonia or
osteoarticular infections, as these are often clinical diagnoses that lack microbiologic confirmation. This may
have led to an underestimation of the true frequency of
SBI. Third, we identified only one case of bacterial meningitis, which limits our conclusions about the predictive
value of viral detections on the diagnosis of meningitis.
Fourth, two modifications to the emvPCR thermocycling
conditions were implemented during the course of this
study to improve assay performance characteristics.
These iterations of development are inherent limitations
of the study, and the true sensitivity and specificity of
the experimental emvPCR compared to a gold standard
are unknown. Finally, another inherent limitation is that
this cohort study lacked a control population to ascertain frequencies of viral detections in afebrile children.
This study was completed prior to the onset of the global pandemic of coronavirus disease 2019 (COVID-19)
[20]. Thus, the impact of SARS-CoV-2 detection on patient management of children in the ED and the association of COVID-19 with SBIs remain important areas
for future research.

Conclusions
In conclusion, viral bloodstream detections were common in children presenting to the ED with suspected
systemic infection who had blood culture obtained, and
the predominant viruses were enterovirus and adenovirus. However, the frequency of SBIs among subjects
with and without viral bloodstream detections were not
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significantly different. Viral bloodstream detections did
have high negative predictive values for bacteremia and
meningitis, but could not rule out UTI. Overall, these results indicate that viral molecular testing of the bloodstream may be useful for determining the likelihood of
bacteremia or meningitis, but must be interpreted in the
context of other clinical and laboratory parameters and
the presence of risk factors for UTIs.
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